cms pharma
  • Home
  • Services
  • Business Landscape
  • Team
  • News
  • Contact us

CMS Pharma is a specialist M&A and corporate strategy advisor to the Chemicals, Pharmaceuticals and Industrial sectors.

As independent and objective advisors, we assist our clients evaluate strategic options by designing customized M&A strategies to address their challenges. We run buy-side and sell-side engagements (divestitures), fund-raising rounds, restructuring and benchmarking studies.

We work tirelessly to maintain a broad network of relationships with industrial and private equity companies in the USA, Europe, Middle-East and India. Our extensive deal experience and our network are the cornerstone of our effectiveness.

We adhere to the principle of placing clients’ interests first. We strive to achieve a reputation of excellence and integrity. We are committed to meet our clients’ highest expectations, consistently.

CMS News

2013-06-04
Asia Biotech Invest 2013:
Examining key trends in biotech M&A
Read more

2013-04-25
11th EGA Biosimilar Symposium:
Dynamics and Challenges for Biosimilars-2.0
Read more

2013-03-06
Contract Pharma:
Supergenerics & The Future of Pharma
Read more

2012-10-08
Manufacturing Chemist - October Cover Story:
Top Five Global Trends Direct Strategic Thinking
Read more